The Gyros™ immunoassay platform brings increased productivity and efficiency to the development of biotherapeutics and vaccines, saving time and labor.
Major biopharmaceutical companies and their service providers utilize the Gyros platform to boost time-critical workflows and to meet increasing regulatory demands on testing.
Spanning the entire spectrum of immunoassays, the platform accelerates assay development, minimizes sample consumption and cuts the time to result.
The ease of assay transfer between sites and from development to regulated environments is unsurpassed in the industry.
Gyrolab xP workstation transfers samples and reagents from microplates to each microstructure within a Gyrolab CD and spins each CD at precisely the correct...